Patents by Inventor Thomas W. Myers

Thomas W. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120208239
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: July 11, 2011
    Publication date: August 16, 2012
    Applicant: Roche Molecualr Systems, Inc.
    Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
  • Publication number: 20120190008
    Abstract: The present invention provides a method for the amplification of at least a first and a second target nucleic acid that may be present in a fluid sample. The invention further provides a kit and an analytical system for carrying out said amplification.
    Type: Application
    Filed: July 27, 2011
    Publication date: July 26, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Meike Eickhoff, Niclas Hitziger, Anke Mussmann, Thomas W. Myers, Christopher Newhouse, Nicolas Newton, John Niemiec, Nancy Schoenbrunner, Edward S. Smith, Stephen G. Will, Heike Wilts, Dirk Zimmermann
  • Patent number: 8163487
    Abstract: The present invention provides methods of extending primer nucleic acids and sequencing target nucleic acids. The methods include the use of 2?-terminator nucleotides to effect chain termination. In addition to related reaction mixtures and kits, the invention also provides computers and computer readable media.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: April 24, 2012
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David Harrow Gelfand, Fred Lawrence Reichert, Veeraiah Bodepudi, Amar Gupta, Stephen Will, Thomas W. Myers
  • Publication number: 20120015405
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: January 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: FRED REICHERT, KEITH BAUER, THOMAS W. MYERS
  • Publication number: 20120009628
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: January 12, 2012
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Publication number: 20110318785
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 29, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: FRED REICHERT, KEITH BAUER, THOMAS W. MYERS
  • Publication number: 20110318786
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 29, 2011
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Publication number: 20110312039
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 22, 2011
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Publication number: 20110312037
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 22, 2011
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Publication number: 20110312038
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: FRED REICHERT, KEITH BAUER, THOMAS W. MYERS
  • Publication number: 20110312041
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: FRED REICHERT, KEITH BAUER, THOMAS W. MYERS, NANCY J. SCHOENBRUNNER, JOSEPH SAN FILIPPO
  • Patent number: 7598032
    Abstract: Modified thermostable DNA polymerases having enhanced efficiency for incorporating unconventional nucleotides such as those labeled with fluorescein family dyes are advantageous in many in vitro DNA synthesis applications. Such enzymes are particularly useful for use in chain termination nucleic acid sequencing protocols, as are native forms of such enzymes. Genes encoding the modified enzymes and methods for their production and use offer cost and efficiency advantages for DNA sequencing.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: October 6, 2009
    Assignee: Roche Molecular Systems
    Inventors: David Harrow Gelfand, Lisa Vivian Kalman, Fred Lawrence Reichert, Christopher Lim Sigua, Thomas W. Myers
  • Publication number: 20090142810
    Abstract: The present invention provides methods of extending primer nucleic acids and sequencing target nucleic acids. The methods include the use of 2?-terminator nucleotides to effect chain termination. In addition to related reaction mixtures and kits, the invention also provides computers and computer readable media.
    Type: Application
    Filed: July 16, 2008
    Publication date: June 4, 2009
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: David Harrow Gelfand, Fred Lawrence Reichert, Veeraiah Bodepudi, Amar Gupta, Stephen Will, Thomas W. Myers
  • Patent number: 7148049
    Abstract: The present invention provides thermostable or thermoactive DNA polymerases with attenuated 3?-5? exonuclease activity, methods for their synthesis, methods for their use, kits comprising the polymerases, nucleic acids encoding the polymerases and cells comprising such a nucleic acid. The DNA polymerases of the invention are useful in many recombinant DNA techniques, such as nucleic acid amplification by the polymerase chain reaction. The DNA polymerases of the invention allow higher fidelity replication and amplification of a template DNA sequence, allow less degradation of primers and/or more efficient use of deoxynucleotide triphosphates and are in general more efficient and less costly to make and use.
    Type: Grant
    Filed: March 26, 2003
    Date of Patent: December 12, 2006
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Nancy J. Schoenbrunner, Thomas W. Myers, David H. Gelfand
  • Patent number: 6751239
    Abstract: A system and method are disclosed for communicating multimedia information. Exemplary embodiments provide a Video-to-Optical apparatus (“V2O”) that can be used over either a private or a public optical network and transfers multimedia information in SONET/SDH frame format. The V2O uses SONET/SDH frames to transmit high-resolution stereoscopic images and other multimedia information through an optical network with high efficiency, high accuracy and low latency. The V2O interfaces with a visualization graphics-server on one side and the optical network on the other. The V2O apparatus can be placed in an optical network that offers an end-to-end OC 3 or higher rate circuit. A plurality of multimedia visualization centers can be coupled to the optical network.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: June 15, 2004
    Assignee: Teraburst Networks, Inc.
    Inventors: Lakshmi Raman, Christopher W. Weller, Thomas W. Myers, Jay Couch, Craig Paulsen, Thomas Wood, Mark Sapper
  • Publication number: 20040005599
    Abstract: The present invention provides thermostable or thermoactive DNA polymerases with attenuated 3′-5′ exonuclease activity, methods for their synthesis, methods for their use, kits comprising the polymerases, nucleic acids encoding the polymerases and cells comprising such a nucleic acid. The DNA polymerases of the invention are useful in many recombinant DNA techniques, such as nucleic acid amplification by the polymerase chain reaction. The DNA polymerases of the invention allow higher fidelity replication and amplification of a template DNA sequence, allow less degradation of primers and/or more efficient use of deoxynucleotide triphosphates and are in general more efficient and less costly to make and use.
    Type: Application
    Filed: March 26, 2003
    Publication date: January 8, 2004
    Inventors: Nancy J. Schoenbrunner, Thomas W. Myers, David H. Gelfand
  • Patent number: 6668106
    Abstract: The present invention combines several features to create a novel type of optical telecommunications switching component using microwave waveguides as opposed to the usual methods employing light deflection or digital signal processing. Some of the components of the device include: (1) an optical crossconnect (OXC) which allows any combination of wavelengths to be added or dropped from an element to an optical network, (2) an optical add/drop multiplexer (OADM) which allows any wavelength to be converted to any other, (3) a microwave crossbar switch array optimized for this purpose, and (4) a means for reshaping the exiting signal from the microwave crosspoint switch array without regard to signal format and without need for complex and expensive digital signal processing. The minimal architecture for this functionality is shown to be three N×N microwave crossbar switch arrays.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: December 23, 2003
    Assignee: Teraburst Networks, Inc.
    Inventors: Jules D. Levine, Thomas W. Myers, Christopher Weller
  • Publication number: 20030152988
    Abstract: Modified thermostable DNA polymerases having enhanced efficiency for incorporating unconventional nucleotides such as those labeled with fluorescein family dyes are advantageous in many in vitro DNA synthesis applications. Such enzymes are particularly useful for use in chain termination nucleic acid sequencing protocols, as are native forms of such enzymes. Genes encoding the modified enzymes and methods for their production and use offer cost and efficiency advantages for DNA sequencing.
    Type: Application
    Filed: January 30, 2003
    Publication date: August 14, 2003
    Inventors: David Harrow Gelfand, Lisa Vivian Kalman, Fred Lawrence Reichert, Christopher Lim Sigua, Thomas W. Myers
  • Publication number: 20030076558
    Abstract: A system and method are disclosed for communicating multimedia information. Exemplary embodiments provide a Video-to-Optical apparatus (“V2O”) that can be used over either a private or a public optical network and transfers multimedia information in SONET/SDH frame format. The V2O uses SONET/SDH frames to transmit high-resolution stereoscopic images and other multimedia information through an optical network with high efficiency, high accuracy and low latency. The V2O interfaces with a visualization graphics-server on one side and the optical network on the other. The V2O apparatus can be placed in an optical network that offers an end-to-end OC 3 or higher rate circuit. A plurality of multimedia visualization centers can be coupled to the optical network.
    Type: Application
    Filed: October 7, 2002
    Publication date: April 24, 2003
    Inventors: Lakshmi Raman, Christopher W. Weller, Thomas W. Myers, Jay Couch, Craig Paulsen, Thomas Wood, Mark Sapper
  • Publication number: 20020142333
    Abstract: Modified thermostable DNA polymerases having enhanced efficiency for incorporating unconventional nucleotides such as those labeled with fluorescein family dyes are advantageous in many in vitro DNA synthesis applications. Such enzymes are particularly useful for use in chain termination nucleic acid sequencing protocols, as are native forms of such enzymes. Genes encoding the modified enzymes and methods for their production and use offer cost and efficiency advantages for DNA sequencing.
    Type: Application
    Filed: January 17, 2002
    Publication date: October 3, 2002
    Applicant: F. Hoffmann-La Roche AG.
    Inventors: David Harrow Gelfand, Lisa Vivian Kalman, Fred Lawrence Reichert, Christopher Lim Sigua, Thomas W. Myers